Receive Your Medication STEP 3 3 / 3 Physician guidance for dose adjustments, side-effect management, and long-term success
In the SSTR4 agonist space, mazisotine was the only candidate to reach Phase II, followed by FZ002-037 a drug co-developed by Simcere MSD (Shanghai) Pharmaceuticals Co Ltd and Fermion which remains in Phase I
After incubation, immunocomplexes were retrieved using a magnetic stand, and the supernatant was discarded
At room temperature [25C (77F)]: Stable for 5 days when stored at room temperature
After synthesis, FOXO4-DRI undergoes purification by high-performance liquid chromatography (HPLC) , followed by mass spectrometry (MS) to verify the peptide's purity and molecular integrity
These include constipation, nausea, diarrhea, bloating, and gas